MEDICONSEMedico Remedies Limited· Pharmaceuticals & BiotechnologyHighNegative
Announced Tue, 24 Feb, 2026 · 17:48 IST

Medico Remedies Limited has informed the Exchange about Action(s) taken or orders passed

Sebi PenaltyRegulatory & Legal View source PDFExplain this filing

MEDICO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.9%Reaction day
₹45.94
prior close
₹45.45
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.2%-1.1% vs market
Pharmaceuticals peers, median of 158sector+0.0%-0.9% vs sector

On the reaction day the stock moved 1.1 pts less than Nifty Microcap 250 and 0.9 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+1.8
10m
+2.0
15m
+1.9
30m
+1.9
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.9+0.2-1.1+0.0-0.9
Next day
-1.4+0.4-1.8+0.4-1.8
2d
-2.9-0.6-2.3-0.5-2.4
3d
-7.4-2.8-4.6-2.1-5.3
4d
-7.4-5.4-1.9-3.2-4.2
5d
-10.1-4.4-5.6-1.8-8.3
1w
-11.8-7.1-4.8-4.2-7.6
15d
-17.3-7.8-9.5-5.4-11.9
1m
-22.4-6.6-15.8-6.1-16.3
2m
-9.8+7.7-17.5+3.2-13.0
3m
+6.5+10.3-3.7+7.0-0.5
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 158Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Medico Remedies Limited received a Standard Operating Procedure (SoP) notice from both NSE and BSE on 20th February 2026 for alleged non-compliance of Regulation 6(1) of SEBI Listing Regulations, which deals with the appointment of a Compliance Officer. Each exchange has levied a penalty of Rs. 63,720 (inclusive of GST) on the company. In response, the company filed a Waiver Application with both NSE and BSE on 24th February 2026, seeking to get the fine waived. The company has confirmed there is no material impact on its financials, operations, or other activities due to this matter.

Likely market impact

This is a minor compliance penalty worth only Rs. 63,720 from each exchange, which is negligible compared to typical company operations. With a waiver already filed, the stock price is unlikely to be meaningfully affected.